Hypercholesterolemia
Conditions
Brief summary
To determine the effect of investigational products on serum LDL cholesterol.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* healthy mildly to moderate hypercholesterolemic (serum total cholesterol 5.2-8.5 mmol/l) adults * signed written informed consent
Exclusion criteria
* participation in a clinical study within 30 days prior to screening visit and throughout the study * severe obesity * consumption of lipid/cholesterol lowering medication 1 month prior to the screening visit and throughout the study * consumption of plant stanol or plant sterol containing food products such as Benecol or Becel pro active 1 month prior to visit 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in serum LDL cholesterol | 0 vs 4 weeks |
Countries
Sweden